Caiwen Du

1.3k total citations
45 papers, 803 citations indexed

About

Caiwen Du is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Caiwen Du has authored 45 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Caiwen Du's work include HER2/EGFR in Cancer Research (9 papers), Retinoids in leukemia and cellular processes (8 papers) and Cancer Treatment and Pharmacology (7 papers). Caiwen Du is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Retinoids in leukemia and cellular processes (8 papers) and Cancer Treatment and Pharmacology (7 papers). Caiwen Du collaborates with scholars based in China, United States and Hong Kong. Caiwen Du's co-authors include Guo‐Jun Zhang, Wen-Jia Chen, Xiaoli Li, Jiaxin Shen, Jing Liu, Hua-Tao Wu, Xiaolong Wei, Jing‐Wen Bai, Ping Yang and Xiaowei Dou and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Caiwen Du

39 papers receiving 789 citations

Peers

Caiwen Du
David Cervi United States
Jessica A. Beach United States
Joëlle Collignon Belgium
Maurizia Mello‐Grand Italy
Chun Sun China
Sujatha Jagadeeswaran United States
Santai Song China
Alysha K. Croker Canada
Igor Bado United States
David Cervi United States
Caiwen Du
Citations per year, relative to Caiwen Du Caiwen Du (= 1×) peers David Cervi

Countries citing papers authored by Caiwen Du

Since Specialization
Citations

This map shows the geographic impact of Caiwen Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caiwen Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caiwen Du more than expected).

Fields of papers citing papers by Caiwen Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caiwen Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caiwen Du. The network helps show where Caiwen Du may publish in the future.

Co-authorship network of co-authors of Caiwen Du

This figure shows the co-authorship network connecting the top 25 collaborators of Caiwen Du. A scholar is included among the top collaborators of Caiwen Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caiwen Du. Caiwen Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Xue, Jing Hu, Hui Zheng, et al.. (2025). Clinicopathological Features and Prognoses of Patients With Splenic Metastases From Breast Cancer: A Single-Centre, Retrospective Study. Cancer Control. 32. 2925728626–2925728626.
2.
3.
4.
Chen, Xuelian, et al.. (2024). The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer. Cancer Medicine. 13(8). e7181–e7181. 3 indexed citations
5.
6.
Xu, Fei, Yongkui Lu, Caiwen Du, et al.. (2024). Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis. npj Breast Cancer. 10(1). 45–45. 3 indexed citations
7.
Chen, Xuelian, et al.. (2023). A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancer. Frontiers in Oncology. 13. 1122294–1122294. 5 indexed citations
8.
9.
10.
Liu, Jing, Jiaxin Shen, Hua-Tao Wu, et al.. (2018). Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target.. PubMed. 25(139). 211–223. 181 indexed citations
11.
Lin, Haoyu, Yuanke Liang, Xiaowei Dou, et al.. (2018). Notch3 inhibits epithelial–mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression. Oncogenesis. 7(8). 59–59. 35 indexed citations
12.
Dou, Xiaowei, Yuanke Liang, Haoyu Lin, et al.. (2017). Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α. Theranostics. 7(16). 4041–4056. 50 indexed citations
13.
Wei, Xiaolong, Xiaowei Dou, Jing‐Wen Bai, et al.. (2015). ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer. Oncotarget. 6(25). 21704–21717. 22 indexed citations
14.
Chen, Wen-Jia, Caiwen Du, Si-Qi Qiu, et al.. (2014). Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China. Scientific Reports. 4(1). 5360–5360. 18 indexed citations
15.
Du, Caiwen, et al.. (2013). Research progress on bilateral breast cancer. 40(3). 208–211. 1 indexed citations
16.
Peng, Xulong, et al.. (2013). Clinical features and prognostic factors in patients with nasopharyngeal carcinoma relapse after primary treatment. Head & Neck Oncology. 5(2). 21. 9 indexed citations
17.
Yang, Ping, et al.. (2013). The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis. Scientific Reports. 3(1). 2246–2246. 63 indexed citations
18.
19.
Du, Caiwen, et al.. (2012). Effect of arsenic trioxide on Epstein-Barr virus latent membrane protein 1-mediated E-cadherin silencing in nasopharyngeal carcinoma. Head & Neck Oncology. 4(2). 55. 3 indexed citations
20.
Du, Caiwen, et al.. (2004). Arsenic Trioxide Induced Differentiation and Apoptosis in Human Nasopharyngeal Carcinoma Xenografts in BALB/C Nude Mice. The Chinese-German Journal of Clinical Oncology. 3(3). 151–155. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Cervi Breakdown of academic impact, for papers by Jessica A. Beach Breakdown of academic impact, for papers by Joëlle Collignon Breakdown of academic impact, for papers by Maurizia Mello‐Grand Breakdown of academic impact, for papers by Chun Sun Breakdown of academic impact, for papers by Sujatha Jagadeeswaran Breakdown of academic impact, for papers by Santai Song Breakdown of academic impact, for papers by Alysha K. Croker Breakdown of academic impact, for papers by Igor Bado
Rankless by CCL
2026